Kyle B. Matchett

600 total citations
26 papers, 435 citations indexed

About

Kyle B. Matchett is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kyle B. Matchett has authored 26 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kyle B. Matchett's work include RNA Interference and Gene Delivery (5 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Kyle B. Matchett is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Kyle B. Matchett collaborates with scholars based in United Kingdom, United States and Ireland. Kyle B. Matchett's co-authors include Mohamed El‐Tanani, Terence R.J. Lappin, Ahmed Faheem, Paul A. McCarron, Yusuf A. Haggag, James A. L. Brown, Niamh Lynam‐Lennon, Ken Mills, R. William G. Watson and Suzanne McFarlane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Kyle B. Matchett

26 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle B. Matchett United Kingdom 14 243 89 55 52 42 26 435
Theodoros Karampelas Greece 11 172 0.7× 96 1.1× 32 0.6× 41 0.8× 18 0.4× 17 377
Yiwei Qi China 10 202 0.8× 34 0.4× 83 1.5× 22 0.4× 13 0.3× 21 406
Linhong Liu China 13 186 0.8× 54 0.6× 59 1.1× 16 0.3× 69 1.6× 22 449
Shihong Shao China 12 86 0.4× 69 0.8× 36 0.7× 50 1.0× 17 0.4× 27 368
Zixue Xuan China 12 233 1.0× 107 1.2× 114 2.1× 38 0.7× 11 0.3× 34 423
Ying Shen China 6 197 0.8× 58 0.7× 67 1.2× 71 1.4× 8 0.2× 10 398
Paul Hoppenz Germany 8 236 1.0× 89 1.0× 39 0.7× 40 0.8× 9 0.2× 11 455
Rajwinder Dhami United States 11 298 1.2× 31 0.3× 38 0.7× 48 0.9× 21 0.5× 12 625
Gregory M. Cresswell United States 9 121 0.5× 83 0.9× 34 0.6× 42 0.8× 16 0.4× 17 348

Countries citing papers authored by Kyle B. Matchett

Since Specialization
Citations

This map shows the geographic impact of Kyle B. Matchett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle B. Matchett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle B. Matchett more than expected).

Fields of papers citing papers by Kyle B. Matchett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle B. Matchett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle B. Matchett. The network helps show where Kyle B. Matchett may publish in the future.

Co-authorship network of co-authors of Kyle B. Matchett

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle B. Matchett. A scholar is included among the top collaborators of Kyle B. Matchett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle B. Matchett. Kyle B. Matchett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gawne, Peter J., Helen E. Bryant, Steven G. DuBois, et al.. (2025). Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better. Journal of Nuclear Medicine. 66(4). 490–496. 1 indexed citations
2.
Matchett, Kyle B., et al.. (2023). A systematic review and meta-analysis of the SIRT1 response to exercise. Scientific Reports. 13(1). 14752–14752. 15 indexed citations
3.
El‐Tanani, Mohamed, Angela Platt‐Higgins, Hamdi Nsairat, et al.. (2023). Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer. Life Sciences. 329. 121964–121964. 8 indexed citations
4.
Feng, Jie, et al.. (2021). Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment. Journal of Nanobiotechnology. 19(1). 279–279. 14 indexed citations
5.
Davis, Lindsay, et al.. (2020). A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia. Scientific Reports. 10(1). 18514–18514. 8 indexed citations
6.
Song, Daisheng, Wei Guan, Tao Wang, et al.. (2020). Tibetan PHD2 , an allele with loss-of-function properties. Proceedings of the National Academy of Sciences. 117(22). 12230–12238. 30 indexed citations
7.
Sharma, Ankur, Paul A. McCarron, Kyle B. Matchett, Susan Hawthorne, & Mohamed El‐Tanani. (2018). Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells. Pharmaceutical Research. 36(2). 26–26. 13 indexed citations
8.
Tekko, Ismaiel A., et al.. (2018). Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays. Journal of Pharmaceutical Sciences. 107(9). 2439–2450. 26 indexed citations
9.
Matchett, Kyle B., Ivan Grishagin, Laura M. Kettyle, et al.. (2017). High-Throughput Screen Identification of Albendazole As a Novel Repurposed Drug in Acute Myeloid Leukaemia. Blood. 130. 5062–5062. 3 indexed citations
10.
Haggag, Yusuf A., Kyle B. Matchett, Paul Buchanan, et al.. (2017). Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. International Journal of Pharmaceutics. 521(1-2). 40–53. 44 indexed citations
11.
Matchett, Kyle B., Jonathan A. Coulter, Hiu‐Fung Yuen, et al.. (2017). Erythropoietin drives breast cancer progression by activation of its receptor EPOR. Oncotarget. 8(24). 38251–38263. 28 indexed citations
12.
McEvoy, Claire T., Ruth F. Hunter, Kyle B. Matchett, et al.. (2017). Exploring perceived support of postgraduate medical science research students. Journal of Further and Higher Education. 42(4). 454–466. 6 indexed citations
13.
Brown, James A. L., Tríona Ní Chonghaile, Kyle B. Matchett, Niamh Lynam‐Lennon, & Patrick A. Kiely. (2016). Big Data–Led Cancer Research, Application, and Insights. Cancer Research. 76(21). 6167–6170. 7 indexed citations
14.
Kettyle, Laura M., Kyle B. Matchett, Joanne M. Ramsey, et al.. (2016). Low-dose salinomycin induces anti-leukemic responses in AML and MLL. Oncotarget. 7(45). 73448–73461. 14 indexed citations
15.
Matchett, Kyle B., Ivan Grishagin, Laura M. Kettyle, et al.. (2016). Mebendazole: A candidate FDA approved drug for repurposing in leukaemia. Research Portal (Queen's University Belfast). 2 indexed citations
16.
Matchett, Kyle B., Mary Frances McMullin, Yahia El‐Tanani, et al.. (2015). Protein deregulation associated with breast cancer metastasis. Cytokine & Growth Factor Reviews. 26(4). 415–423. 9 indexed citations
17.
Busacca, Sara, Ian Powley, David A. Proia, et al.. (2015). Resistance to HSP90 inhibition involving loss of MCL1 addiction. Oncogene. 35(12). 1483–1492. 24 indexed citations
18.
Savage, Kienan I., Kyle B. Matchett, K Cooper, et al.. (2014). BRCA1 Deficiency Exacerbates Estrogen-Induced DNA Damage and Genomic Instability. Cancer Research. 74(10). 2773–2784. 8 indexed citations
19.
Matchett, Kyle B., et al.. (2014). Ran GTPase in Nuclear Envelope Formation and Cancer Metastasis. Advances in experimental medicine and biology. 323–351. 46 indexed citations
20.
Boyle, David P., et al.. (2013). Molecular and clinicopathological markers of prognosis in breast cancer. Expert Review of Molecular Diagnostics. 13(5). 481–498. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodoros Karampelas Breakdown of academic impact, for papers by Yiwei Qi Breakdown of academic impact, for papers by Linhong Liu Breakdown of academic impact, for papers by Shihong Shao Breakdown of academic impact, for papers by Zixue Xuan Breakdown of academic impact, for papers by Ying Shen Breakdown of academic impact, for papers by Paul Hoppenz Breakdown of academic impact, for papers by Rajwinder Dhami Breakdown of academic impact, for papers by Gregory M. Cresswell
Rankless by CCL
2026